Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-25 Sale | 2022-05-27 7:20 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 702,737 | $4.1236 | $2,897,806 | 1,905,430 (Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 7:45 pm | Elevation Oncology Inc. | ELEV | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC 10% Owner | 312,500 | $16 | $5,000,000 | 2,370,142 (Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 6:29 pm | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 187,500 | $16 | $3,000,000 | 2,834,910 (Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 5:27 pm | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 625,000 | $16 | $10,000,000 | 2,608,167 (Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 4:24 pm | Elevation Oncology Inc. | ELEV | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 250,000 | $16 | $4,000,000 | 2,233,168 (Indirect) | View |
| 2021-06-29 Purchase | 2021-06-29 4:07 pm | Elevation Oncology Inc. | ELEV | Vertex Global HC Fund II Pte. Ltd. 10% Owner | 250,000 | $16 | $4,000,000 | 2,307,642 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-16 Tax Withholding | 2023-03-20 4:21 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr INTERIM CEO & CFO | 4,773 | $2.35 | 167,581 (Direct) | View |
| 2023-03-16 Exercise | 2023-03-20 4:21 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr INTERIM CEO & CFO | 12,563 | $0 | 167,581 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:29 pm | N/A 2033-02-14 | Elevation Oncology Inc. | ELEV | Jansen Valerie Malyvanh CHIEF MEDICAL OFFICER | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:26 pm | N/A 2033-02-14 | Elevation Oncology Inc. | ELEV | Dornan David CHIEF SCIENTIFIC OFFICER | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 4:23 pm | N/A 2033-02-14 | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr INTERIM CEO & CFO | 270,000 | $0 | 270,000 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 4:30 pm | N/A 2033-01-05 | Elevation Oncology Inc. | ELEV | Jansen Valerie Malyvanh CHIEF MEDICAL OFFICER | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 4:27 pm | N/A 2033-01-05 | Elevation Oncology Inc. | ELEV | Dornan David CHIEF SCIENTIFIC OFFICER | 130,000 | $0 | 130,000 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 4:24 pm | N/A 2033-01-05 | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr INTERIM CEO & CFO | 270,000 | $0 | 270,000 (Direct) | View |
| 2022-06-16 Exercise | 2022-12-19 7:40 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr CHIEF FINANCIAL OFFICER | 75,373 | $0 | 461,284 (Direct) | View |
| 2022-12-16 Tax Withholding | 2022-12-19 7:40 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr CHIEF FINANCIAL OFFICER | 4,773 | $0.95 | 461,284 (Direct) | View |
| 2022-09-16 Tax Withholding | 2022-12-19 7:40 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr CHIEF FINANCIAL OFFICER | 4,773 | $1.25 | 461,284 (Direct) | View |
| 2022-06-16 Tax Withholding | 2022-12-19 7:40 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr CHIEF FINANCIAL OFFICER | 19,095 | $1.26 | 461,284 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:45 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Walsh Colin Director | 15,619 | $0 | 15,619 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:44 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Hu Lori Director | 15,619 | $0 | 15,619 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:43 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 15,619 | $0 | 15,619 (Indirect) | View |
| 2022-05-31 Gift | 2022-06-22 6:42 pm | N/A N/A | Elevation Oncology Inc. | ELEV | CLACKSON TIMOTHY P Director | 31,553 | $0 | 62,949 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:42 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | CLACKSON TIMOTHY P Director | 15,619 | $0 | 62,949 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:41 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Carruthers R Michael Director | 15,619 | $0 | 15,619 (Direct) | View |
| 2022-03-14 Option Award | 2022-03-16 5:46 pm | N/A 2032-03-13 | Elevation Oncology Inc. | ELEV | Dornan David Chief Scientific Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 8:09 pm | N/A 2032-02-13 | Elevation Oncology Inc. | ELEV | Jansen Valerie Malyvanh Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 8:08 pm | N/A 2032-02-13 | Elevation Oncology Inc. | ELEV | Leland Shawn President, CEO | 186,500 | $0 | 186,500 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-16 8:07 pm | N/A 2032-02-13 | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr Chief Financial Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-10-19 Option Award | 2021-10-21 6:32 pm | N/A 2031-10-18 | Elevation Oncology Inc. | ELEV | Jansen Valerie Malyvanh Chief Medical Officer | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2021-10-21 6:29 pm | N/A 2031-05-06 | Elevation Oncology Inc. | ELEV | Jansen Valerie Malyvanh Chief Medical Officer | 0 | $0 | 158,654 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 7:45 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC 10% Owner | 10,752,372 | $0 | 2,370,142 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 6:29 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 12,288,426 | $0 | 2,834,910 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 5:27 pm | N/A N/A | Elevation Oncology Inc. | ELEV | venBio Global Strategic Fund III L.P. VENBIO GLOBAL STRATEGIC GP III L.P. GOODMAN COREY S Adelman Robert J Royston Aaron 10% Owner | 10,363,201 | $0 | 2,608,167 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 4:24 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 1,983,168 | $0 | 2,233,168 (Indirect) | View |
| 2021-06-29 Conversion | 2021-06-29 4:07 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Vertex Global HC Fund II Pte. Ltd. 10% Owner | 10,752,372 | $0 | 2,307,642 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:26 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Gaster Richard Director | 31,238 | $0 | 31,238 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:24 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Hu Lori Director | 31,238 | $0 | 31,238 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:23 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Ferra Joseph J Jr Chief Financial Officer | 450,099 | $0 | 450,099 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:21 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Walsh Colin Director | 31,238 | $0 | 31,238 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:18 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 31,238 | $0 | 31,238 (Indirect) | View |
Ownership | 2021-06-24 6:33 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Vertex Global HC Fund II Pte. Ltd. 10% Owner | 0 | $0 | 2,057,642 (Direct) | View |
Ownership | 2021-06-24 6:32 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP ELMS STEVE Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N 10% Owner | 0 | $0 | 2,647,410 (Direct) | View |
Ownership | 2021-06-24 6:16 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Qiming U.S. Healthcare Fund II L.P. Qiming U.S. Healthcare GP II LLC 10% Owner | 0 | $0 | 2,057,642 (Direct) | View |
Ownership | 2021-06-24 6:14 pm | N/A N/A | Elevation Oncology Inc. | ELEV | CLACKSON TIMOTHY P Director | 0 | $0 | 47,330 (Direct) | View |
Ownership | 2021-06-24 6:11 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Leland Shawn President, CEO | 0 | $0 | 1,484,620 (Direct) | View |
Ownership | 2021-06-24 6:07 pm | N/A 2031-05-06 | Elevation Oncology Inc. | ELEV | Carruthers R Michael Director | 0 | $0 | 47,330 (Direct) | View |